Carregant...
Neuroproteomics in Epilepsy: What Do We Know so Far?
Epilepsies are chronic neurological diseases that affect approximately 2% of the world population. In addition to being one of the most frequent neurological disorders, treatment for patients with epilepsy remains a challenge, because a proportion of patients do not respond to the antiseizure medica...
Guardat en:
| Publicat a: | Front Mol Neurosci |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Frontiers Media S.A.
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7817846/ https://ncbi.nlm.nih.gov/pubmed/33488359 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fnmol.2020.604158 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|